Find Academic Supervisors

• Maternal-Fetal Medicine
• Obstetric Ultrasound
• Fetal Development
• +3 more

Dr. Emily Lee serves as an Assistant Professor at Yale School of Medicine in the Department of Obstetrics, Gynecology & Reproductive Sciences, with a clinical focus in Maternal-Fetal Medicine. She completed her Maternal-Fetal Medicine fellowship at Yale in 2023 following her Obstetrics & Gynecology residency at UCLA. Dr. Lee earned her MD from the University of Michigan and completed her undergraduate studies at Yale University with a BA in Economics and Religious Studies. Dr. Lee's research primarily focuses on advancing fetal monitoring techniques, particularly in the areas of obstetric ultrasound and non-invasive fetal electroencephalography. Her work explores innovative approaches to prenatal diagnosis, fetal development assessment, and improving clinical outcomes in complex pregnancies including twin gestations. She has developed simulation-based educational programs for obstetric ultrasound training that enhance clinical skills for medical learners. Her recent publications demonstrate a strong emphasis on improving diagnostic accuracy in fetal cardiac assessment, understanding the implications of maternal obesity on prenatal procedures, and developing novel methods for non-invasive fetal neurological monitoring. Dr. Lee's research bridges clinical practice with technological innovation in maternal-fetal medicine. Among her notable recognitions are the prestigious 2024 Blavatnik Award and the Yale Innovation Summit Blavatnik Accelerator Award in 2023, highlighting her contributions to medical innovation. She has also received the Best Maternal-Fetal Medicine Oral Presentation award from the New England Perinatal Society in 2023, along with earlier recognition for her research at UCLA and international conferences. Dr. Lee actively contributes to medical education through her Point-of-Care Ultrasound Simulation Curriculum and regularly presents on topics including substance use in pregnancy, marijuana usage effects, and advanced fetal monitoring techniques. Her work with the Reproductive Sciences department at Yale focuses on translating research into clinical practice to improve maternal and fetal outcomes.

Manisha GandhiView profile

Professor

• Maternal-Fetal Medicine
• Obstetrics and Gynecology
• Cardio-Obstetrics
• +7 more

Dr. Manisha Gandhi is a Professor in the Department of Obstetrics and Gynecology at Baylor College of Medicine and a key clinician at Texas Children's Pavilion for Women in Houston, TX. She specializes in Maternal-Fetal Medicine and currently serves as Vice Chair for Clinical Affairs. Previously, she was Section Chief for Maternal-Fetal Medicine from 2017 to 2022. Education: MD, University of Texas Health Science Center, San Antonio (2002) BA, Biochemistry, Rice University, Houston (1998) Residency, Obstetrics and Gynecology, Mount Sinai School of Medicine, New York (2006) Fellowship, Maternal-Fetal Medicine, Mount Sinai School of Medicine, New York (2009) Her research and clinical interests focus on high-risk pregnancies , particularly those complicated by maternal cardiovascular disease and multiple gestations . She co-developed a collaborative cardio-obstetrics clinic integrating adult congenital heart disease and MFM expertise. She performs prenatal diagnostic procedures such as amniocentesis and chorionic villus sampling. Her work emphasizes health equity , as seen in her research on reducing racial disparities in maternal morbidity through quality improvement initiatives. Her recent publications span topics including COVID-19 in pregnancy , fetal genetic disorders , and national clinical guidelines . The articles reflect a strong orientation toward public health, clinical outcomes, and translational research in maternal-fetal medicine. Scientific Awards and Recognition: Award of Excellence in Teaching from Medical Students at Baylor College of Medicine Award of Excellence in Teaching from Residents at Baylor College of Medicine Dr. Gandhi holds significant leadership roles in clinical governance and national policy. She chairs the Clinical Specialty Committee and the Quality Assessment and Performance Improvement Committee at Texas Children’s Pavilion for Women. She served on the Baylor Faculty Senate (2015–2020) and is currently the Chair of the American College of Obstetricians and Gynecologists (ACOG) Clinical Practice Guidelines Committee (2023–2025). She previously served on the Society for Maternal-Fetal Medicine Publications Committee. Her work in mentoring and grant-funded research is implied through her leadership and publications, though specific grants and advisees are not listed. She is involved in institutional and national committees focused on enhancing women’s reproductive health and improving clinical standards. No specific lab or research team is mentioned, but her collaborative work in cardio-obstetrics and quality improvement suggests active team-based clinical research.

Karen FloodView profile

Senior Lecturer

• Maternal Fetal Medicine
• Prenatal Diagnosis
• Pregnancy Loss
• +3 more

Karen Flood is a Consultant in Obstetrics and Gynaecology and Subspecialist in Maternal Fetal Medicine at the Royal College of Surgeons in Ireland (RCSI). She serves as a Senior Lecturer and leads the early pregnancy service and recurrent pregnancy loss clinic at Rotunda Hospital. Her clinical expertise includes prenatal screening, diagnosis, and management of high-risk pregnancies, with a focus on recurrent pregnancy loss, twin pregnancies, and benign gynaecology. Education: MD from RCSI (2001); specialist training in Dublin and New York. Research: Doctorate thesis on platelet function in pregnancy loss; ongoing work in perinatal genetics. Karen’s research contributions center on prenatal diagnostics, including amniocentesis, chorionic villus sampling (CVS), and non-invasive prenatal testing (NIPT). She is actively involved in medical education at undergraduate and postgraduate levels. Her awards include recognition for research in maternal-fetal medicine and prenatal screening. Contact: Private Gynaecology Patients: privateadmin@rotunda.ie | Private Obstetric Patients: karenflood@rcsi.ie

• Next Generation Sequencing
• Genetics
• Medical Genetics
• +7 more

Eddy de Boer is an active academic researcher affiliated with the University of Groningen , contributing to advancements in medical genetics, genomics, and diagnostic technologies. His work spans prenatal diagnostics, neurological disorders, and cancer genomics, with recent publications in 2024 and 2025. Key Research Areas : Genomic Diagnostics, Long-Read Sequencing, Trisomy Prediction Collaborations : Active in epidermolysis bullosa and leukemia diagnostics through interdisciplinary partnerships His research aligns with UN Sustainable Development Goals for health and innovation. Current work includes improving non-invasive prenatal testing (NIPT) and next-generation sequencing (NGS) applications for newborn screening. Recent publications demonstrate expertise in resolving complex genomic structures (e.g., repeat expansions) using advanced sequencing techniques. Notably, he contributed to the development of the NIPTeR and GAVIN software packages for trisomy prediction and variant interpretation. In media engagement, de Boer contributed to the Sequencing Buyer’s Guide (2023), highlighting his role in disseminating genomic research to broader audiences.

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Gestational Diabetes
• +3 more

Paola Galoppi is a Researcher at Sapienza University of Rome's Department of Maternal, Infant and Urological Sciences, teaching Pathological Obstetrics for Midwifery and Gynecology/Obstetrics courses for Medicine and Surgery students. Her clinical-academic role bridges obstetric practice with maternal-fetal research, focusing on high-risk pregnancy management within Rome's public healthcare system. Her research centers on gestational diabetes pathophysiology, autoimmune disorders (particularly systemic lupus erythematosus) in pregnancy, and complications including thrombocytopenia, hypertension, and fetal growth abnormalities. She investigates metabolic-immunological interactions in adipose tissue, viral transmissions like SARS-CoV-2, and rare conditions such as homozygous familial hypercholesterolemia during gestation. Her methodology emphasizes clinical case reports, systematic reviews, and case-control studies to address evidence gaps in obstetric practice. Analysis of her 2022-2025 publications reveals emerging trends: innovative management of dyslipidemias via lipoprotein apheresis, hybrid closed-loop insulin systems for diabetic pregnancies, and critical reappraisal of fetal monitoring protocols. She actively documents SARS-CoV-2 vertical transmission mechanisms while exploring pharmacological safety (e.g., elexacaftor/tezacaftor/ivacaftor) and hematological interventions for alloimmunization. No scientific awards were documented in the provided institutional records. No information regarding student supervision or research grant acquisition was specified in the source materials, though her clinical case reports suggest collaboration with obstetric teams at Rome's public hospitals. Dr. Galoppi contributes to the institutional research group focused on Gestational diabetes; Risk Factors; Outcomes , indicating active participation in multi-center studies examining metabolic predictors of adverse pregnancy events within Italy's universal healthcare framework.

• Prenatal Diagnosis
• Gynecological Ultrasound
• Obstetrics and Gynecology
• +4 more

Maria Grazia Piccioni is an Associate Professor at Sapienza University of Rome's Faculty of Medicine and Odontology, Department of Maternal and Child Health and Urological Sciences. She serves as Director of Prenatal Diagnosis and provides clinical services in gynecological ultrasound, performing over 4,000 pelvic, transvaginal, and interventional procedures annually. Her academic roles span multiple degree programs including Medicine, Midwifery, Nursing, and Health Assistance. Her research focuses on prenatal diagnostics , gynecological ultrasound applications , and pregnancy complications . Key interests include fetal alcohol spectrum disorders (evident in her 2024-2025 Italian guidelines publications), endometriosis management, autoimmune diseases in pregnancy, and cancer diagnostics during gestation. Her recent publications demonstrate strong emphasis on ultrasound innovation for placental disorders and fetal anomalies. She coordinates ERASMUS+ programs with universities in Liège and Granada since 2011, and has led MIUR-funded research projects including 'Morpho-functional cardiovascular changes in menopause'. Her clinical expertise includes 500 annual interventional ultrasound procedures (amniocentesis, chorionic villus sampling, cyst aspirations). Awards include MIUR research grants and leadership roles in international educational initiatives. Her teaching portfolio encompasses Obstetrics/Gynecology for Medical, Midwifery, and Nursing programs, including specialized courses in prenatal diagnostics and ultrasound. She has supervised numerous theses and serves as Vice President of Sapienza's Midwifery program. Research collaborations include the 'Reproductive history in BRCA1/2 mutation carriers' project and Bolivian thyroid disorder studies.

Katherine ConnollyView profile

Assistant Professor

• Maternal-Fetal Medicine
• Reproductive Genetics
• Obstetrics
• +3 more

Katherine Connolly, MD is an Assistant Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco (UCSF) School of Medicine. She is affiliated with the Maternal-Fetal Medicine & Reproductive Genetics division, providing specialized care for high-risk pregnancies and reproductive genetic services. Dr. Connolly's research focuses on maternal-fetal medicine, with particular interest in: Clinical care and maternal clinical disease characteristics Maternal and neonatal outcomes Fertility treatments Amniocentesis and prenatal diagnostic procedures Maternal and fetal medicine quality and safety Her work primarily examines obstetric procedures, pregnancy complications, and interventions to improve maternal and fetal outcomes. Dr. Connolly has published research on labor induction techniques, preeclampsia management in multiple gestations, and contemporary approaches to amniocentesis. Her notable achievements include: Arnold P. Gold Humanism Society membership (2009) Outstanding Teacher of Obstetrics and Gynecology award (2012) Dr. Connolly provides clinical services through UCSF Health, with her practice located at 490 Illinois St, Box 0132, San Francisco, CA 94143. Her practice phone number is 415/353-2566.

• Medical Genetics
• Pediatrics
• Genetic Disorders
• +3 more

Linda M. Randolph, MD, is a Clinical Associate Professor in the Department of Pediatrics at the University of Southern California (USC). Her work focuses on medical genetics, neonatal care, and pediatric genetic disorders. She is affiliated with Children’s Hospital Los Angeles (CHLA), where she contributes to clinical and translational research in areas such as genetic diagnostics, prenatal screening, and the management of congenital disorders. Her research emphasizes leveraging genomic technologies—such as exome sequencing and deep learning—for early diagnosis and treatment of conditions like mucopolysaccharidosis, mitochondrial disorders, and neurofibromatosis. She has also investigated chimerism in twins and the clinical implications of genetic variants in pediatric populations. Key contributions include studies on the economic evaluation of early exome sequencing, the application of machine learning in facial dysmorphology analysis, and the correlation between genetic mutations and clinical phenotypes. Her work bridges basic science and clinical practice to improve outcomes for children with rare genetic conditions. Dr. Randolph’s publications span over two decades, reflecting her sustained engagement in pediatric genetics, prenatal diagnosis, and the intersection of genetic medicine with emerging technologies. She has collaborated on projects addressing thalassemia management, twin discordance, and the teratogenic effects of medications.

• Medical Genetics
• Molecular Diagnostics
• Prenatal Genetics
• +5 more

Mark Drost is a Researcher in the Clinical Genetics department at Erasmus University Medical Center (Erasmus MC), Rotterdam. His work focuses on advanced genetic diagnostics with emphasis on prenatal and neurodevelopmental applications. His research spans Medical Genetics , Molecular Diagnostics , and Prenatal Genetics , with specific expertise in DNA methylation analysis, exome sequencing, and Lynch syndrome variant classification. Key methodologies include chorionic villus sampling optimization, trisomy detection protocols, and functional assay development for genetic variant interpretation. Analysis of his recent publications reveals strong focus on clinical implementation of genomic technologies , particularly in prenatal diagnostics (2020-2025). His work demonstrates increasing translation of research into clinical practice, with 2024-2025 publications emphasizing routine diagnostic applications of DNA-methylation signatures and exome sequencing. The research consistently addresses high-impact clinical challenges in trisomy confirmation and neurodevelopmental disorder diagnostics. No scientific awards were documented in the provided materials. Dr. Drost collaborates extensively across Erasmus MC's clinical genetics teams, with co-authorship spanning diagnostic laboratory staff, clinicians, and researchers. His work involves significant grant-supported projects in prenatal genomics and cancer predisposition syndromes, though specific grant details weren't provided. He operates within Erasmus MC's Clinical Genetics department infrastructure, contributing to diagnostic pipelines for trisomy detection, exome sequencing interpretation, and Lynch syndrome variant classification. His research integrates laboratory diagnostics with clinical applications through multidisciplinary teams focused on improving genetic diagnostic yield.

Pauline Wilhelmina BogaardView profile

Associate Clinical Professor

• Pathology
• Perinatal Pathology
• Placental Pathology
• +7 more

Pauline Wilhelmina Bogaard is a Clinical Associate Professor at the Faculty of Medicine, Aalborg University, and works as an Overlæge (Senior Consultant) at Aalborg University Hospital in the Department of Pathology. She is actively involved in research related to perinatal and placental pathology, with a focus on genetic abnormalities and infectious impacts on pregnancy outcomes. Her research interests span placental pathology , prenatal genetic diagnosis , mosaicism in fetal and placental tissues , congenital malformations , and infectious complications during pregnancy . These areas are reflected in her extensive publication record, particularly in high-impact journals in obstetrics and medical genetics. Her work bridges clinical pathology with molecular diagnostics, contributing to improved understanding of fetal and neonatal health. The recent publications indicate a strong trend toward integrating molecular genetic tools into routine perinatal pathology, especially in diagnosing complex cases involving chromosomal mosaicism and viral infections like SARS-CoV-2. Her studies often involve collaborative, multidisciplinary teams across obstetrics, genetics, and pathology. While no formal scientific awards are listed in the provided text, her sustained research output and publication in peer-reviewed journals reflect significant scholarly contribution. She has not been mentioned as advising any students directly, nor are specific grants or funding sources noted. Dr. Bogaard’s work appears to be embedded in a clinical research network at Aalborg University Hospital, particularly within the Department of Pathology and its collaborations with prenatal and obstetric units. Her role suggests active participation in diagnostic services and research initiatives focused on improving perinatal outcomes through advanced pathological and genetic analysis.

• Maternal-Fetal Medicine
• Prenatal Diagnosis
• Fetal Therapy
• +7 more

Joshua Copel, MD, is a Professor at Yale School of Medicine in the Department of Obstetrics, Gynecology and Reproductive Sciences and the Department of Pediatrics. He serves as Vice Chair of Obstetrics, Gynecology and Reproductive Sciences and Assistant Dean of Clinical Affairs at Yale Medicine. He is also affiliated with the Fetal Care Center, High-Risk Pregnancy Program, Maternal Fetal Medicine Unit, and Prenatal Genetic Diagnosis Program. Yale School of Medicine Department of Obstetrics, Gynecology and Reproductive Sciences Department of Pediatrics Fetal Care Center Maternal Fetal Medicine Unit Dr. Copel is a leading expert in maternal-fetal medicine with clinical and research interests in prenatal diagnosis, fetal echocardiography, chorionic villus sampling, amniotic fluid testing, and first-trimester screenings. His research focuses on congenital abnormalities, fetal diseases, and pregnancy complications. He has pioneered new diagnostic techniques for fetal conditions and is passionate about improving global prenatal care through education and guideline development. His recent publications highlight advancements in fetal cardiac screening, ultrasound practice standards, twin pregnancy management, and prenatal diagnostic procedures. These works reflect a strong emphasis on clinical guidelines, diagnostic accuracy, and perinatal outcomes. His research is frequently collaborative, involving key figures in maternal-fetal medicine. Dr. Copel has received notable scientific awards, including: Joseph Holmes Clinical Pioneer Award Dru Carlson Award for best research in Ultrasound He has held leadership roles as President of the Society for Maternal-Fetal Medicine (2010–2011), American Institute of Ultrasound in Medicine (2007–2009), and the International Society of Ultrasound in Obstetrics and Gynecology (2016–2018). He is actively involved in clinical trials, including the STOP BLOQ study on fetal atrioventricular block. He mentors trainees and collaborates extensively, with frequent co-authors including Mert Ozan Bahtiyar, Katherine Kohari, and Tulin Ozcan. Dr. Copel is a key figure in several Yale-affiliated programs, including the Prenatal Laboratory and Yale Ventures. He is recognized as one of Connecticut’s top doctors by Connecticut Magazine .

• Genetics
• Molecular Biology
• Prenatal Diagnosis
• +3 more

Birte Degn serves as a Researcher at the Department of Molecular Diagnostics within the Faculty of Medicine at Aalborg University, based at Aalborg University Hospital. Her clinical and research activities focus on advanced genetic diagnostics in reproductive medicine, contributing to the hospital's molecular testing services and academic research initiatives. Her research spans Genetics and Molecular Biology with concentrated expertise in Prenatal Diagnosis, Preimplantation Genetic Testing (PGT), Genetic Screening methodologies, and Aneuploidy detection. Degn's work addresses critical challenges in non-invasive fetal testing and embryo screening, aiming to improve diagnostic accuracy for monogenic disorders and chromosomal abnormalities through innovative molecular approaches. Analysis of her 2018-2021 publications reveals consistent focus on integrating cell-based non-invasive prenatal testing (cbNIPT) with preimplantation genetic diagnosis, particularly for confirming unaffected fetuses after PGT-M. Her research demonstrates growing emphasis on clinical validation of aneuploidy screening protocols and their impact on reproductive outcomes, reflecting evolving standards in assisted reproductive technology. The Department of Molecular Diagnostics at Aalborg University Hospital provides Degn's primary research infrastructure, where her work supports both clinical diagnostic services and translational research in reproductive genetics. Her collaborative publications indicate active participation in multidisciplinary teams spanning obstetrics, genetics, and embryology.

• Genetics
• Cytogenetics
• Prenatal Genetics
• +5 more

Myrthe van den Born is a Researcher in the Clinical Genetics department at Erasmus MC, a leading medical center in the Netherlands. Her work focuses on advancing prenatal genetic diagnostics through cutting-edge research in cytogenetics and molecular genetics. Her primary research interests include mosaicism, exome sequencing, cytogenetics, chorion villus sampling, and trisomy diagnosis. Dr. van den Born's work has significantly contributed to understanding chromosomal abnormalities in prenatal settings, particularly in the context of placental biology and non-invasive prenatal testing. Analysis of her recent publications reveals a strong focus on improving the accuracy and efficiency of prenatal genetic testing, with particular attention to confirming high-risk NIPT results, understanding confined placental mosaicism, and implementing exome sequencing in clinical practice. Her research consistently addresses practical clinical challenges in prenatal diagnosis. Dr. van den Born has been involved in multiple collaborative research projects, as evidenced by her co-authorship on numerous publications with colleagues from Erasmus MC and other institutions. Her work has garnered attention in the scientific community, with several of her papers being widely read on academic platforms.

• Prenatal Genetic Counseling
• Biomedical Ethics
• Teratology
• +3 more

Amanda S. Higgs, MGC, CGC, serves as Assistant Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of Maryland School of Medicine, where she functions as Senior Genetic Counselor at the Center for Advanced Fetal Care. Her clinical expertise spans comprehensive prenatal genetic counseling for complex cases including family history concerns, abnormal ultrasound findings, advanced maternal age, and teratogen exposure during pregnancy. Her educational background includes: B.S. in Biology from the University of Richmond Master's in Genetic Counseling from the University of Maryland School of Medicine (2000) Ms. Higgs specializes in prenatal genetic counseling with research emphases on biomedical ethics , medication use in pregnancy , and congenital heart disease . Her clinical work addresses critical domains including fetal ultrasound abnormalities, termination of pregnancy for fetal indications, and teleconsultation services, demonstrating commitment to ethical practice and patient-centered care in high-risk obstetric scenarios. Analysis of her publications (2000-2017) reveals consistent focus on improving prenatal diagnostic accuracy, enhancing genetic counseling methodologies, and addressing ethical challenges in maternal-fetal medicine. Key thematic trends include chromosomal abnormality detection, psychiatric genetic counseling frameworks, and integration of genetic services within fetal cardiology programs, reflecting interdisciplinary approaches to complex clinical scenarios. As an educator, she provides clinical supervision for Master's in Genetic Counseling students while mentoring residents, fellows, and medical students. Her collaborative work with the University of Maryland Fetal Heart Program establishes critical bridges between genetic counseling and fetal cardiology services, enhancing comprehensive care models for high-risk pregnancies. She maintains active roles within the Center for Advanced Fetal Care, driving innovation in teleconsultation services and contributing to protocol development for prenatal diagnostic procedures, thereby strengthening institutional capabilities in fetal medicine and genetic risk assessment.

• Maternal-Fetal Medicine
• Obstetrics and Gynecology
• Intrahepatic Cholestasis of Pregnancy
• +3 more

Marc H. Incerpi, MD, serves as Clinical Associate Professor in the Department of Obstetrics and Gynecology at the Keck School of Medicine, University of Southern California. He directs the Medical Student Obstetrics and Gynecology Clerkship and acts as Medical Director of Perinatology at Providence St. Joseph and Providence Holy Cross Medical Centers. An active member of the American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, and American Institute of Ultrasound in Medicine, Dr. Incerpi specializes in high-risk pregnancy care with board certification in obstetrics/gynecology and maternal-fetal medicine. His educational background includes: Medical Degree: Loyola University Chicago Stritch School of Medicine (1992) Residency: Obstetrics & Gynecology, University of Southern California (1992-1996) Fellowship: Maternal-Fetal Medicine, USC (1996-1998) Dr. Incerpi's research centers on maternal-fetal pathophysiology , with landmark studies in intrahepatic cholestasis of pregnancy across Latina populations, obstetric hemorrhage management, and innovative fetal interventions for vasa previa. His clinical focus spans diagnostic ultrasound, stillbirth evaluation, and complications in diabetic pregnancies. Recent work critically examines health disparities in preeclampsia care, demonstrating his commitment to equitable maternal outcomes through both clinical practice and scholarly commentary. Publication analysis (1997-2024) reveals three distinct phases: early diagnostic studies (chorionic villus sampling, fetal MRI), mid-career epidemiological work (cholestasis prevalence, hemorrhage trends), and contemporary focus on health equity ( NEJM 2024 commentary linking aspirin therapy to systemic racism). His 2024 fetoscopic ablation research represents cutting-edge fetal therapy advancement, while longitudinal studies on bile acid monitoring establish evidence-based protocols for high-risk pregnancies. As Clerkship Director, Dr. Incerpi shapes obstetrics education for medical students while maintaining active clinical roles at USC Verdugo Hills Hospital. He contributes to the USC Perinatal Group's multidisciplinary approach to complex pregnancies, emphasizing compassionate care philosophy with dedicated patient-centered practice spanning 25+ years since joining the faculty in 1998.